PMDA drug package insert
カルベジロール錠10mg「TCK」
PMDA Prescription drug · 辰巳化学株式会社 · package insert Jan 31, 2025
Key facts
| Brand names | カルベジロール錠10mg「TCK」, カルベジロール錠20mg「TCK」 |
|---|---|
| Nonproprietary names | カルベジロール |
| Companies | 製造販売元／辰巳化学株式会社, 販売元／日医工株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 持続性 高血圧・狭心症治療剤、慢性心不全治療剤、頻脈性心房細動治療剤（錠10mg）; 持続性 高血圧・狭心症治療剤、頻脈性心房細動治療剤（錠20mg） |
| Therapeutic category codes | 872149 |
| YJ codes | 2149032F1145, 2149032F2150 |
| Approval numbers | 22700AMX00299000, 22700AMX00300000 |
| Package insert edition | 第3版 |
| Package insert date | Jan 31, 2025 |
| PMDA document key | 400278_2149032F1145_2 |
| PMDA company code | 400278 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: